Table 2.
Neuropsychological tests and questionnaires
Domain or goal | Assessment/questionnaires | Duration (min) |
---|---|---|
Cognitive functioning | ||
Overall cognitive functioning | Researcher subjective impression of cognitive health (see “Methods”) | 0 |
Mini–Mental State Examination [26, 86] | 5 | |
National Adult Reading Testa [88–89] | 3 | |
Telephone Interview Cognitive Status—Modified (TICS-M)d [90] | ||
Memory | CERAD 10-word list—immediate and delayed recall [91] | 15 |
Visual Association Test—Memory [92] | 5 | |
Rivermead Behavioral Memory Test (RBMT)b immediate and delayed recall [93, 94] | 6 | |
Attention | Digit Span—forwards [96–97] | 3 |
Trail Making Test A [98, 99] | NA | |
Executive functions | Digit Span—backwards [96–97] | 3 |
Letter Fluency—DAT [101–104] | 2 | |
BADS—subtest Key Search [105, 106] | 3 | |
BADS—subtest Rule Shift Cards [105, 106] | 3 | |
Trail Making Test B [98, 99] | 10 | |
Amsterdam Dementia Screening Test—Meander figure [107] | 2 | |
Language | Category Fluency—Animals [100, 101, 108] | 2 |
Visual Association Test—Naming [92] | 1 | |
Visuo-spatial functioning/construction | CAMDEX-R/N CAMCOG—figure copying [109, 110] | 3 |
Clock Drawing Test [111, 112] | 2 | |
Visual Object and Space Perception (VOSP) Batteryb—subtest Number Location [113] | 3 | |
Depression, ADL, sleep, lifestyle, geriatric impairments | ||
Depressive symptoms | Geriatric Depression Scale-15 (GDS) [29] | 4 |
(Instrumental) Activities of daily living | Informant Questionnaire on Cognitive Decline in the elderly short form (IQ-CODE) [30, 31] | 3 |
Barthel Index [27, 115–116] | 3 | |
Lifetime cognitively stimulating experience | Lifetime Cognitive Activity Scalea [34, 35] | 5 |
Sleep quality | Pittsburgh Sleep Quality Indexa (PSQI) [28] | 5 |
Geriatric impairments | Researcher subjective impression of sight, hearing, mobility (“Methods”) | 0 |
aOnly administered at baseline, b In 100-plus Study-phase 1 only, c Included with the confirmation letter of study-inclusion, collected during the first baseline visit, d Only administered during half yearly-follow up of brain donors and yearly follow-up of siblings